Detailed Mechanism Funding and Narrative

Years of mechanism: 2016 2017 2018 2019 2020

Details for Mechanism ID: 18209
Country/Region: Kenya
Year: 2018
Main Partner: Liverpool VCT, Care and Treatment
Main Partner Program: NA
Organizational Type: NGO
Funding Agency: HHS/CDC
Total Funding: $4,382,617 Additional Pipeline Funding: N/A

NOTE: PEPFAR no longer creates activity narratives for each mechanism. In their place, PEPFAR has begun releasing mechanism specific targets that reveal the achievements and programs that are expected of the funding. If available for this mechanism, these targets are presented below.

Mechanism Allocation by Budget Code for Selected Year
Care: Adult Care and Support (HBHC) $0
Care: Orphans and Vulnerable Children (HKID) $795,145
Care: TB/HIV (HVTB) $9,000
Care: Pediatric Care and Support (PDCS) $0
Laboratory Infrastructure (HLAB) $0
Strategic Information (HVSI) $0
Health Systems Strengthening (OHSS) $0
Biomedical Prevention: Voluntary Medical Male Circumcision (CIRC) $0
Biomedical Prevention: Blood Safety (HMBL) $0
Biomedical Prevention: Injection Safety (HMIN) $0
Sexual Prevention: Abstinence/Be Faithful (HVAB) $226,249
Testing: HIV Testing and Counseling (HVCT) $363,348
Sexual Prevention: Other Sexual Prevention (HVOP) $2,840,593
Prevention: Injecting and Non-Injecting Drug Use (IDUP) $57,282
Biomedical Prevention: Prevention of Mother to Child Transmission (MTCT) $0
Treatment: ARV Drugs (HTXD) $0
Treatment: Adult Treatment (HTXS) $91,000
Treatment: Pediatric Treatment (PDTX) $0
Mechanism Target Information

Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.

MER Indicator MER description Target Fiscal Year Target
GEND_GBV <10, Female, Physical and/or Emotional Violence 2019 126
GEND_GBV <10, Female, Sexual Violence (Post-Rape Care) 2019 126
GEND_GBV <10, Male, Physical and/or Emotional Violence 2019 126
GEND_GBV <10, Male, Sexual Violence (Post-Rape Care) 2019 126
GEND_GBV 10-14, Female, Physical and/or Emotional Violence 2019 380
GEND_GBV 10-14, Female, Sexual Violence (Post-Rape Care) 2019 377
GEND_GBV 10-14, Male, Physical and/or Emotional Violence 2019 126
GEND_GBV 10-14, Male, Sexual Violence (Post-Rape Care) 2019 126
GEND_GBV 15-19, Female, Physical and/or Emotional Violence 2019 1,265
GEND_GBV 15-19, Female, Sexual Violence (Post-Rape Care) 2019 1,269
GEND_GBV 15-19, Male, Physical and/or Emotional Violence 2019 128
GEND_GBV 15-19, Male, Sexual Violence (Post-Rape Care) 2019 126
GEND_GBV 20-24, Female, Physical and/or Emotional Violence 2019 1,778
GEND_GBV 20-24, Female, Sexual Violence (Post-Rape Care) 2019 1,777
GEND_GBV 20-24, Male, Physical and/or Emotional Violence 2019 129
GEND_GBV 20-24, Male, Sexual Violence (Post-Rape Care) 2019 127
GEND_GBV 25-29, Female, Physical and/or Emotional Violence 2019 385
GEND_GBV 25-29, Female, Sexual Violence (Post-Rape Care) 2019 381
GEND_GBV 25-29, Male, Physical and/or Emotional Violence 2019 127
GEND_GBV 25-29, Male, Sexual Violence (Post-Rape Care) 2019 126
GEND_GBV 30-34, Female, Physical and/or Emotional Violence 2019 385
GEND_GBV 30-34, Female, Sexual Violence (Post-Rape Care) 2019 381
GEND_GBV 30-34, Male, Physical and/or Emotional Violence 2019 127
GEND_GBV 30-34, Male, Sexual Violence (Post-Rape Care) 2019 126
GEND_GBV 35-39, Female, Physical and/or Emotional Violence 2019 385
GEND_GBV 35-39, Female, Sexual Violence (Post-Rape Care) 2019 381
GEND_GBV 35-39, Male, Physical and/or Emotional Violence 2019 127
GEND_GBV 35-39, Male, Sexual Violence (Post-Rape Care) 2019 126
GEND_GBV 40-49, Female, Physical and/or Emotional Violence 2019 385
GEND_GBV 40-49, Female, Sexual Violence (Post-Rape Care) 2019 381
GEND_GBV 40-49, Male, Physical and/or Emotional Violence 2019 127
GEND_GBV 40-49, Male, Sexual Violence (Post-Rape Care) 2019 126
GEND_GBV 50+, Female, Physical and/or Emotional Violence 2019 126
GEND_GBV 50+, Female, Sexual Violence (Post-Rape Care) 2019 126
GEND_GBV 50+, Male, Physical and/or Emotional Violence 2019 128
GEND_GBV 50+, Male, Sexual Violence (Post-Rape Care) 2019 125
GEND_GBV By PEP service provision (related to sexual violence services provided) 2019 3,731
GEND_GBV By type of service: Physical and/or Emotional Violence (Other Post-GBV Care) 2019 6,341
GEND_GBV By type of service: Sexual Violence (Post-Rape Care) 2019 6,342
GEND_GBV Number of people receiving post-GBV care 2019 12,675
HTS_SELF 2019 19,078
HTS_SELF 15-19, Female, Directly-Assisted 2019 1,022
HTS_SELF 15-19, Female, Unassisted 2019 1,022
HTS_SELF 15-19, Male, Directly-Assisted 2019 340
HTS_SELF 15-19, Male, Unassisted 2019 340
HTS_SELF 20-24, Female, Directly-Assisted 2019 1,022
HTS_SELF 20-24, Female, Unassisted 2019 1,022
HTS_SELF 20-24, Male, Directly-Assisted 2019 340
HTS_SELF 20-24, Male, Unassisted 2019 340
HTS_SELF 25-29, Female, Directly-Assisted 2019 1,022
HTS_SELF 25-29, Female, Unassisted 2019 1,022
HTS_SELF 25-29, Male, Directly-Assisted 2019 340
HTS_SELF 25-29, Male, Unassisted 2019 340
HTS_SELF 30-34, Female, Directly-Assisted 2019 1,022
HTS_SELF 30-34, Female, Unassisted 2019 1,022
HTS_SELF 30-34, Male, Directly-Assisted 2019 340
HTS_SELF 30-34, Male, Unassisted 2019 340
HTS_SELF 35-39, Female, Directly-Assisted 2019 1,022
HTS_SELF 35-39, Female, Unassisted 2019 1,022
HTS_SELF 35-39, Male, Directly-Assisted 2019 340
HTS_SELF 35-39, Male, Unassisted 2019 340
HTS_SELF 40-49, Female, Directly-Assisted 2019 1,022
HTS_SELF 40-49, Female, Unassisted 2019 1,022
HTS_SELF 40-49, Male, Directly-Assisted 2019 340
HTS_SELF 40-49, Male, Unassisted 2019 340
HTS_SELF 50+, Female, Directly-Assisted 2019 1,022
HTS_SELF 50+, Female, Unassisted 2019 1,022
HTS_SELF 50+, Male, Directly-Assisted 2019 340
HTS_SELF 50+, Male, Unassisted 2019 340
HTS_SELF Directly-Assisted 2019 9,539
HTS_SELF FSW, Directly-Assisted 2019 12,782
HTS_SELF MSM, Directly-Assisted 2019 2,862
HTS_SELF PWID, Directly-Assisted 2019 1,145
HTS_SELF Unassisted 2019 9,539
HTS_SELF Unassisted - Other 2019 953
HTS_SELF Unassisted - Self 2019 4,770
HTS_SELF Unassisted - Sex Partner 2019 3,816
HTS_TST 25-29, Female, Negative 2019 72
HTS_TST 25-29, Female, Negative 2019 8,724
HTS_TST 25-29, Female, Negative 2019 2
HTS_TST 25-29, Female, Negative 2019 50
HTS_TST 25-29, Female, Negative 2019 220
HTS_TST 25-29, Male, Negative 2019 123
HTS_TST 25-29, Male, Negative 2019 3,646
HTS_TST 25-29, Male, Negative 2019 5
HTS_TST 25-29, Male, Negative 2019 104
HTS_TST 25-29, Male, Negative 2019 466
HTS_TST 30-34, Female, Negative 2019 81
HTS_TST 30-34, Female, Negative 2019 9,968
HTS_TST 30-34, Female, Negative 2019 3
HTS_TST 30-34, Female, Negative 2019 58
HTS_TST 30-34, Female, Negative 2019 254
HTS_TST 30-34, Male, Negative 2019 142
HTS_TST 30-34, Male, Negative 2019 4,374
HTS_TST 30-34, Male, Negative 2019 6
HTS_TST 30-34, Male, Negative 2019 124
HTS_TST 30-34, Male, Negative 2019 554
HTS_TST 35-39, Female, Negative 2019 19
HTS_TST 35-39, Female, Negative 2019 2,492
HTS_TST 35-39, Female, Negative 2019 1
HTS_TST 35-39, Female, Negative 2019 17
HTS_TST 35-39, Female, Negative 2019 61
HTS_TST 35-39, Male, Negative 2019 554
HTS_TST 35-39, Male, Negative 2019 142
HTS_TST 35-39, Male, Negative 2019 4,374
HTS_TST 35-39, Male, Negative 2019 6
HTS_TST 35-39, Male, Negative 2019 124
HTS_TST 40-49, Female, Negative 2019 61
HTS_TST 40-49, Female, Negative 2019 19
HTS_TST 40-49, Female, Negative 2019 2,492
HTS_TST 40-49, Female, Negative 2019 1
HTS_TST 40-49, Female, Negative 2019 17
HTS_TST 40-49, Male, Negative 2019 185
HTS_TST 40-49, Male, Negative 2019 50
HTS_TST 40-49, Male, Negative 2019 1,457
HTS_TST 40-49, Male, Negative 2019 2
HTS_TST 40-49, Male, Negative 2019 40
HTS_TST By Key Population: FSW, Negative 2019 17,306
HTS_TST By Key Population: MSM, Negative 2019 3,172
HTS_TST By Key Population: PWID, Negative 2019 1,497
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2019 120,886
HTS_TST Service Delivery Point (Community) Index Mod: <1, Negative 2019 60
HTS_TST Service Delivery Point (Community) Index Mod: 1-9, Negative 2019 162
HTS_TST Service Delivery Point (Community) Index Mod: 10-14, Female, Negative 2019 39
HTS_TST Service Delivery Point (Community) Index Mod: 10-14, Male, Negative 2019 32
HTS_TST Service Delivery Point (Community) Index Mod: 15-19, Female, Negative 2019 282
HTS_TST Service Delivery Point (Community) Index Mod: 15-19, Male, Negative 2019 129
HTS_TST Service Delivery Point (Community) Index Mod: 20-24, Female, Negative 2019 969
HTS_TST Service Delivery Point (Community) Index Mod: 20-24, Male, Negative 2019 422
HTS_TST Service Delivery Point (Community) Index Mod: 50+, Female, Negative 2019 10
HTS_TST Service Delivery Point (Community) Index Mod: 50+, Male, Negative 2019 24
HTS_TST Service Delivery Point (Community) Mobile Testing: 15-19, Female, Negative 2019 1,068
HTS_TST Service Delivery Point (Community) Mobile Testing: 15-19, Male, Negative 2019 510
HTS_TST Service Delivery Point (Community) Mobile Testing: 20-24, Female, Negative 2019 3,677
HTS_TST Service Delivery Point (Community) Mobile Testing: 20-24, Male, Negative 2019 1,631
HTS_TST Service Delivery Point (Community) Mobile Testing: 50+, Female, Negative 2019 33
HTS_TST Service Delivery Point (Community) Mobile Testing: 50+, Male, Negative 2019 94
HTS_TST Service Delivery Point (Community) VCT Mod: 15-19, Female, Negative 2019 11
HTS_TST Service Delivery Point (Community) VCT Mod: 15-19, Male, Negative 2019 5
HTS_TST Service Delivery Point (Community) VCT Mod: 20-24, Female, Negative 2019 38
HTS_TST Service Delivery Point (Community) VCT Mod: 20-24, Male, Negative 2019 17
HTS_TST Service Delivery Point (Community) VCT Mod: 50+, Male, Negative 2019 1
HTS_TST Service Delivery Point (Facility) Index: <1, Negative 2019 32
HTS_TST Service Delivery Point (Facility) Index: 1-9, Negative 2019 75
HTS_TST Service Delivery Point (Facility) Index: 10-14, Female, Negative 2019 23
HTS_TST Service Delivery Point (Facility) Index: 10-14, Male, Negative 2019 18
HTS_TST Service Delivery Point (Facility) Index: 15-19, Female, Negative 2019 241
HTS_TST Service Delivery Point (Facility) Index: 15-19, Male, Negative 2019 112
HTS_TST Service Delivery Point (Facility) Index: 20-24, Female, Negative 2019 827
HTS_TST Service Delivery Point (Facility) Index: 20-24, Male, Negative 2019 807
HTS_TST Service Delivery Point (Facility) Index: 50+, Female, Negative 2019 8
HTS_TST Service Delivery Point (Facility) Index: 50+, Male, Negative 2019 20
HTS_TST Service Delivery Point (Facility) VCT: <1, Negative 2019 28
HTS_TST Service Delivery Point (Facility) VCT: 1-9, Negative 2019 73
HTS_TST Service Delivery Point (Facility) VCT: 10-14, Female, Negative 2019 19
HTS_TST Service Delivery Point (Facility) VCT: 10-14, Male, Negative 2019 17
HTS_TST Service Delivery Point (Facility) VCT: 15-19, Female, Negative 2019 10,467
HTS_TST Service Delivery Point (Facility) VCT: 15-19, Male, Negative 2019 3,608
HTS_TST Service Delivery Point (Facility) VCT: 20-24, Female, Negative 2019 36,052
HTS_TST Service Delivery Point (Facility) VCT: 20-24, Male, Negative 2019 11,548
HTS_TST Service Delivery Point (Facility) VCT: 50+, Female, Negative 2019 1,248
HTS_TST Service Delivery Point (Facility) VCT: 50+, Male, Negative 2019 728
HTS_TST_POS 25-29, Female, Positive 2019 4
HTS_TST_POS 25-29, Female, Positive 2019 196
HTS_TST_POS 25-29, Female, Positive 2019 189
HTS_TST_POS 25-29, Female, Positive 2019 2
HTS_TST_POS 25-29, Male, Positive 2019 9
HTS_TST_POS 25-29, Male, Positive 2019 52
HTS_TST_POS 25-29, Male, Positive 2019 106
HTS_TST_POS 25-29, Male, Positive 2019 4
HTS_TST_POS 30-34, Female, Positive 2019 4
HTS_TST_POS 30-34, Female, Positive 2019 221
HTS_TST_POS 30-34, Female, Positive 2019 213
HTS_TST_POS 30-34, Female, Positive 2019 2
HTS_TST_POS 30-34, Male, Positive 2019 9
HTS_TST_POS 30-34, Male, Positive 2019 63
HTS_TST_POS 30-34, Male, Positive 2019 128
HTS_TST_POS 30-34, Male, Positive 2019 4
HTS_TST_POS 35-39, Female, Positive 2019 54
HTS_TST_POS 35-39, Female, Positive 2019 52
HTS_TST_POS 35-39, Male, Positive 2019 4
HTS_TST_POS 35-39, Male, Positive 2019 9
HTS_TST_POS 35-39, Male, Positive 2019 63
HTS_TST_POS 35-39, Male, Positive 2019 128
HTS_TST_POS 40-49, Female, Positive 2019 54
HTS_TST_POS 40-49, Female, Positive 2019 52
HTS_TST_POS 40-49, Male, Positive 2019 1
HTS_TST_POS 40-49, Male, Positive 2019 21
HTS_TST_POS 40-49, Male, Positive 2019 44
HTS_TST_POS By Key Population: FSW, Positive 2019 288
HTS_TST_POS By Key Population: MSM, Positive 2019 116
HTS_TST_POS By Key Population: PWID, Positive 2019 27
HTS_TST_POS Service Delivery Point (Community) Index Mod: 15-19, Female, Positive 2019 16
HTS_TST_POS Service Delivery Point (Community) Index Mod: 15-19, Male, Positive 2019 7
HTS_TST_POS Service Delivery Point (Community) Index Mod: 20-24, Female, Positive 2019 50
HTS_TST_POS Service Delivery Point (Community) Index Mod: 20-24, Male, Positive 2019 22
HTS_TST_POS Service Delivery Point (Community) Index Mod: 50+, Male, Positive 2019 1
HTS_TST_POS Service Delivery Point (Community) Mobile Testing: 15-19, Female, Positive 2019 10
HTS_TST_POS Service Delivery Point (Community) Mobile Testing: 15-19, Male, Positive 2019 5
HTS_TST_POS Service Delivery Point (Community) Mobile Testing: 20-24, Female, Positive 2019 32
HTS_TST_POS Service Delivery Point (Community) Mobile Testing: 20-24, Male, Positive 2019 13
HTS_TST_POS Service Delivery Point (Community) Mobile Testing: 50+, Male, Positive 2019 1
HTS_TST_POS Service Delivery Point (Facility) Index: 15-19, Female, Positive 2019 287
HTS_TST_POS Service Delivery Point (Facility) Index: 15-19, Male, Positive 2019 111
HTS_TST_POS Service Delivery Point (Facility) Index: 20-24, Female, Positive 2019 958
HTS_TST_POS Service Delivery Point (Facility) Index: 20-24, Male, Positive 2019 378
HTS_TST_POS Service Delivery Point (Facility) Index: 50+, Female, Positive 2019 28
HTS_TST_POS Service Delivery Point (Facility) Index: 50+, Male, Positive 2019 22
HTS_TST_POS Service Delivery Point (Facility) VCT: 15-19, Female, Positive 2019 171
HTS_TST_POS Service Delivery Point (Facility) VCT: 15-19, Male, Positive 2019 48
HTS_TST_POS Service Delivery Point (Facility) VCT: 20-24, Female, Positive 2019 591
HTS_TST_POS Service Delivery Point (Facility) VCT: 20-24, Male, Positive 2019 153
HTS_TST_POS Service Delivery Point (Facility) VCT: 50+, Female, Positive 2019 29
HTS_TST_POS Service Delivery Point (Facility) VCT: 50+, Male, Positive 2019 10
KP_PREV By key population type: Female sex workers (FSW) (Numerator: Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required) 2019 11,665
KP_PREV By key population type: Females who inject drugs (Female PWID) (Numerator: Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required) 2019 45
KP_PREV By key population type: Males who inject drugs (Male PWID) (Numerator: Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required) 2019 2,848
KP_PREV By key population type: Men who have sex with men who are NOT sex workers (Numerator: Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required) 2019 4,888
KP_PREV Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required 2019 19,446
OVC_SERV Age/Sex: <1 2019 147
OVC_SERV Age/Sex: 1-9 2019 4,089
OVC_SERV Age/Sex: 10-14 Female 2019 2,630
OVC_SERV Age/Sex: 10-14 Male 2019 1,395
OVC_SERV Age/Sex: 15-17 Female 2019 1,904
OVC_SERV Age/Sex: 15-17 Male 2019 715
OVC_SERV By: Age/sex: 18-24 Female 2019 1,255
OVC_SERV By: Age/sex: 25+ Female 2019 26
OVC_SERV By: Age/sex: Male 18-24 2019 409
OVC_SERV By: Age/sex: Male 25+ 2019 6
OVC_SERV Number of active beneficiaries served by PEPFAR OVC programs for children and families affected by HIV/AIDS 2019 12,571
OVC_SERV Program Completion: Active 2019 12,529
OVC_SERV Program Completion: Graduation 42 Number of orphans and vulnerable children (<18 years old) whose HIV status is known or unknown by the OVC implementing partner. 10,874 Number of active beneficiaries served by PEPFAR OVC programs for children and families affected by HIV/AIDS 2019 12,571
OVC_SERV Required only for DREAMS countries - By service, age and sex: Economic Strengthening Female 10-14 2019 181
OVC_SERV Required only for DREAMS countries - By service, age and sex: Economic Strengthening Female 15-17 2019 465
OVC_SERV Required only for DREAMS countries - By service, age and sex: Economic Strengthening Female 18-24 2019 606
OVC_SERV Required only for DREAMS countries - By service, age and sex: Economic Strengthening Male 10-14 2019 5
OVC_SERV Required only for DREAMS countries - By service, age and sex: Economic Strengthening Male 15-17 2019 5
OVC_SERV Required only for DREAMS countries - By service, age and sex: Economic Strengthening Male 18-24 2019 3
OVC_SERV Required only for DREAMS countries - By service, age and sex: Education Support Female 10-14 2019 1,894
OVC_SERV Required only for DREAMS countries - By service, age and sex: Education Support Female 15-17 2019 6,598
OVC_SERV Required only for DREAMS countries - By service, age and sex: Education Support Female 18-24 2019 699
OVC_SERV Required only for DREAMS countries - By service, age and sex: Education Support Male 10-14 2019 85
OVC_SERV Required only for DREAMS countries - By service, age and sex: Education Support Male 15-17 2019 3,064
OVC_SERV Required only for DREAMS countries - By service, age and sex: Education Support Male 18-24 2019 35
OVC_SERV Required only for DREAMS countries - By service, age and sex: Other Services Female 10-14 2019 3,001
OVC_SERV Required only for DREAMS countries - By service, age and sex: Other Services Female 15-17 2019 4,254
OVC_SERV Required only for DREAMS countries - By service, age and sex: Other Services Female 18-24 2019 3,678
OVC_SERV Required only for DREAMS countries - By service, age and sex: Other Services Female 25+ 2019 151
OVC_SERV Required only for DREAMS countries - By service, age and sex: Other Services Male 10-14 2019 282
OVC_SERV Required only for DREAMS countries - By service, age and sex: Other Services Male 15-17 2019 236
OVC_SERV Required only for DREAMS countries - By service, age and sex: Other Services Male 18-24 2019 29
OVC_SERV Required only for DREAMS countries - By service, age and sex: Other Services Male 25+ 2019 3
OVC_SERV Required only for DREAMS countries - By service, age and sex: Parenting/Caregiver Programs Female 10-14 2019 797
OVC_SERV Required only for DREAMS countries - By service, age and sex: Parenting/Caregiver Programs Female 15-17 2019 230
OVC_SERV Required only for DREAMS countries - By service, age and sex: Parenting/Caregiver Programs Female 18-24 2019 8
OVC_SERV Required only for DREAMS countries - By service, age and sex: Parenting/Caregiver Programs Female 25+ 2019 435
OVC_SERV Required only for DREAMS countries - By service, age and sex: Parenting/Caregiver Programs Male 10-14 2019 186
OVC_SERV Required only for DREAMS countries - By service, age and sex: Parenting/Caregiver Programs Male 15-17 2019 156
OVC_SERV Required only for DREAMS countries - By service, age and sex: Parenting/Caregiver Programs Male 18-24 2019 7
OVC_SERV Required only for DREAMS countries - By service, age and sex: Parenting/Caregiver Programs Male 25+ 2019 1
OVC_SERV Required only for DREAMS countries - By service, age and sex: Social Protection Female 10-14 2019 75
OVC_SERV Required only for DREAMS countries - By service, age and sex: Social Protection Female 15-17 2019 398
OVC_SERV Required only for DREAMS countries - By service, age and sex: Social Protection Female 18-24 2019 445
OVC_SERV Required only for DREAMS countries - By service, age and sex: Social Protection Male 10-14 2019 8
OVC_SERV Required only for DREAMS countries - By service, age and sex: Social Protection Male 15-17 2019 5
OVC_SERV Required only for DREAMS countries - By service, age and sex: Social Protection Male 18-24 2019 1
OVC_SERV Sum of Age/Sex disaggregates 2019 6,644
PP_PREV 25-29, Female 2019 248
PP_PREV 25-29, Male 2019 121
PP_PREV 30-34, Female 2019 248
PP_PREV 30-34, Male 2019 121
PP_PREV 35-39, Female 2019 248
PP_PREV 35-39, Male 2019 121
PP_PREV 40-49, Female 2019 248
PP_PREV 40-49, Male 2019 121
PP_PREV Age/sex: 10-14 Female 2019 612
PP_PREV Age/sex: 10-14 Male 2019 41
PP_PREV Age/sex: 15-19 Female 2019 1,627
PP_PREV Age/sex: 15-19 Male 2019 545
PP_PREV Age/sex: 20-24 Female 2019 1,768
PP_PREV Age/sex: 20-24 Male 2019 366
PP_PREV Age/sex: 50+ Female 2019 167
PP_PREV Age/sex: 50+ Male 2019 50
PP_PREV Number of the target population who completed a standardized HIV prevention intervention including the minimum components during the reporting period 2019 11,853
PP_PREV Sum of Age/Sex disaggregates 2019 5,176
PrEP_NEW 25-29, Female 2019 67
PrEP_NEW 25-29, Male 2019 29
PrEP_NEW 30-34, Female 2019 47
PrEP_NEW 30-34, Male 2019 38
PrEP_NEW 35-39, Female 2019 47
PrEP_NEW 35-39, Male 2019 38
PrEP_NEW 40-49, Female 2019 47
PrEP_NEW 40-49, Male 2019 29
PrEP_NEW Female 15-19 2019 116
PrEP_NEW Female 20-24 2019 393
PrEP_NEW Female 50+ 2019 20
PrEP_NEW FSW 2019 134
PrEP_NEW Male 15-19 2019 9
PrEP_NEW Male 20-24 2019 58
PrEP_NEW Male 50+ 2019 20
PrEP_NEW MSM 2019 67
PrEP_NEW Number of individuals who have been newly enrolled on oral antiretroviral pre-exposure prophylaxis (PrEP) in the reporting period to prevent HIV infection 2019 956
TB_ART Aggregated Age/Sex: Female 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2019 8
TB_ART Aggregated Age/Sex: Male 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2019 10
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period 2019 18
TB_PREV By Age/Sex (Numerator): <15, Female 2019 6
TB_PREV By Age/Sex (Numerator): <15, Male 2019 7
TB_PREV By Age/Sex (Numerator): 15+, Female 2019 99
TB_PREV By Age/Sex (Numerator): 15+, Male 2019 57
TB_PREV The number of ART patients who completed a course of TB preventive therapy or at least 6 months of Isoniazid Preventive Therapy (IPT) during the reporting period 2019 170
TB_PREV The number of ART patients who were newly started on TB preventive therapy (including those who newly started on TB preventive therapy in this reporting period and those who started in the previous reporting period but had not been reported as they did not fulfill the minimum requirements for the previous reporting period) 2019 198
TB_PREV_den By Age/Sex (Denominator): <15, Female 2019 7
TB_PREV_den By Age/Sex (Denominator): <15, Male 2019 8
TB_PREV_den By Age/Sex (Denominator): 15+, Female 2019 117
TB_PREV_den By Age/Sex (Denominator): 15+, Male 2019 66
TB_PREV_den IPT, Life-long ART, New, Positive 2019 198
TB_STAT Aggregated Age/Sex: Female <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2019 1
TB_STAT Aggregated Age/Sex: Female 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2019 9
TB_STAT Aggregated Age/Sex: Male <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2019 1
TB_STAT Aggregated Age/Sex: Male 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2019 14
TB_STAT Number of registered new and relapsed TB cases with documented HIV status, during the reporting period 2019 24
TB_STAT Total number of registered new and relapsed TB cases, during the reporting period 2019 24
TB_STAT_den Aggregated Age/Sex: Female <15 (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2019 1
TB_STAT_den Aggregated Age/Sex: Female 15+ (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2019 9
TB_STAT_den Aggregated Age/Sex: Male <15 (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2019 1
TB_STAT_den Aggregated Age/Sex: Male 15+ (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2019 14
TX_CURR 25-29, Female, Positive 2019 756
TX_CURR 25-29, Male, Positive 2019 224
TX_CURR 30-34, Female, Positive 2019 574
TX_CURR 30-34, Male, Positive 2019 353
TX_CURR 35-39, Female, Positive 2019 574
TX_CURR 35-39, Male, Positive 2019 353
TX_CURR 40-49, Female, Positive 2019 392
TX_CURR 40-49, Male, Positive 2019 353
TX_CURR Age/Sex: <1 2019 1
TX_CURR Age/Sex: <1-9 2019 30
TX_CURR Age/Sex: 10-14 Female 2019 16
TX_CURR Age/Sex: 10-14 Male 2019 15
TX_CURR Age/Sex: 15-19 Female 2019 127
TX_CURR Age/Sex: 15-19 Male 2019 71
TX_CURR Age/Sex: 20-24 Female 2019 359
TX_CURR Age/Sex: 20-24 Male 2019 92
TX_CURR Age/Sex: 50+ Female 2019 311
TX_CURR Age/Sex: 50+ Male 2019 128
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2019 4,723
TX_CURR Sum of age/sex disaggregates 2019 198
TX_NEW 25-29, Female, Positive 2019 42
TX_NEW 25-29, Male, Positive 2019 31
TX_NEW 30-34, Female, Positive 2019 48
TX_NEW 30-34, Male, Positive 2019 37
TX_NEW 35-39, Female, Positive 2019 12
TX_NEW 35-39, Male, Positive 2019 37
TX_NEW 40-49, Female, Positive 2019 12
TX_NEW 40-49, Male, Positive 2019 12
TX_NEW Breastfeeding status 2019 7
TX_NEW By Age/Sex: 15-19 Female 2019 80
TX_NEW By Age/Sex: 15-19 Male 2019 32
TX_NEW By Age/Sex: 20-24 Female 2019 278
TX_NEW By Age/Sex: 20-24 Male 2019 102
TX_NEW By Age/Sex: 50+ Female 2019 5
TX_NEW By Age/Sex: 50+ Male 2019 6
TX_NEW FSW 2019 16
TX_NEW MSM 2019 7
TX_NEW Number of adults and children newly enrolled on antiretroviral therapy (ART) 2019 736
TX_NEW People in prisons and other enclosed settings 2019 3
TX_NEW Pregnancy status 2019 85
TX_NEW Sum of Age/Sex disaggregates 2019 503
TX_NEW TG 2019 1
TX_PVLS Number of adult and pediatric ART patients with a viral load result documented in the patient medical record and /or laboratory records in the past 12 months 2019 4,947
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: <15 Female Routine 2019 31
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: <15 Female Targeted 2019 5
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: <15 Male Routine 2019 39
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: <15 Male Targeted 2019 9
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: 15+ Female Routine 2019 2,886
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: 15+ Female Targeted 2019 182
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: 15+ Male Routine 2019 1,659
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: 15+ Male Targeted 2019 136
TX_PVLS_den Denominator: Indication: Routine 2019 4,615
TX_PVLS_den Denominator: Indication: Targeted 2019 332
TX_RET Aggregated Age/Sex: 15+ Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2019 5
TX_RET Aggregated Age/Sex: 15+ Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2019 2
TX_RET Number of adults and children who are still alive and on treatment at 12 months after initiating ART 2019 826
TX_RET Numerator by Status: Breastfeeding 2019 15
TX_RET Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up 2019 845
TX_RET_den Aggregated Age/Sex: 15+ Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2019 573
TX_RET_den Aggregated Age/Sex: 15+ Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2019 264
TX_RET_den Denominator by Status: Breastfeeding 2019 13
TX_RET_den Denominator by Status: Pregnant 2019 70
TX_TB Number of ART patients who were screened for TB at least once during the reporting period 2019 4,723
TX_TB_den Denominator: By Aggregated Age/Sex: <15, Female 2019 117
TX_TB_den Denominator: By Aggregated Age/Sex: <15, Male 2019 118
TX_TB_den Denominator: By Aggregated Age/Sex:15+, Female 2019 3,041
TX_TB_den Denominator: By Aggregated Age/Sex:15+, Male 2019 1,448
TX_TB_den Denominator: By Diagnostic Test [Subdisagg of Specimen Sent]: Gene Xpert MTB / R if Assay 2019 100
TX_TB_den Denominator: By Diagnostic Test [Subdisagg of Specimen Sent]: Smear Only 2019 45
TX_TB_den Denominator: Number of ART patients who had a specimen sent for bacteriologic diagnosis of active TB disease 2019 151
Cross Cutting Budget Categories and Known Amounts Total: $3,614,698
Key Populations: MSM and TG $19,500
Implementation of core HIV prevention interventions for MSM/TG that are consistent with the current PEPFAR technical guidance
Collection and use of strategic information
Key Populations: Sex Workers $19,500
Training of health workers and community outreach workers
Collection and use of strategic information on SWs and clients
Gender: Gender Based Violence (GBV) $50,000
GBV Prevention
Implementation
Capacity building
Post GBV Care
Implementation
Capacity building
Gender: Gender Equality $50,000
Equity in HIV prevention, care, treatment and support
Implementation
Capacity building
Adolescent Girls and Young Women (AGYW) $3,097,549
Motor Vehicles: Purchased $51,020
Renovation $61,224
Human Resources for Health $265,905